Get started
Author

Kazunori Kageyama

Observed names: K Kageyama, K. Kageyama, KAZUNORI KAGEYAMA, Kazunori KAGEYAMA
ORCID: 0000-0003-0662-5231
Observed ORCID: 0000-0003-0662-5231
OpenAlex ID: A5079755873
Urocortin Messenger Ribonucleic Acid: Tissue Distribution in the Rat and Regulation in Thymus by Lipopolysaccharide and Glucocorticoids
1999 · Kazunori Kageyama, Margaret J. Bradbury, et al. · Endocrinology · 128
Hypothalamic Regulation of Corticotropin-Releasing Factor under Stress and Stress Resilience
2021 · Kazunori Kageyama, Yasumasa Iwasaki, et al. · International Journal of Molecular Sciences · 117
PDF
Management of immune-related adverse events in endocrine organs induced by immune checkpoint inhibitors: clinical guidelines of the Japan Endocrine Society
2019 · Hiroshi Arima, Shintaro Iwama, et al. · Endocrine Journal · 115
PDF
Association between Higher Serum Cortisol Levels and Decreased Insulin Secretion in a General Population
2016 · Aya Kamba, Makoto Daimon, et al. · PLoS ONE · 107
PDF
Physiological roles of urocortins, human homologues of fish urotensin I, and their receptors
2004 · Toshihiro Suda, Kazunori Kageyama, et al. · Peptides · 99
Regulatory Mechanisms Underlying Corticotropin-Releasing Factor Gene Expression in the Hypothalam
2009 · Kazunori KAGEYAMA, Toshihiro SUDA · Endocrine Journal · 96
PDF
New diagnostic criteria of adrenal subclinical Cushing’s syndrome: opinion from the Japan Endocrine Society
2018 · Toshihiko Yanase, Yutaka Oki, et al. · Endocrine Journal · 95
PDF
Regulation of Corticotropin-Releasing Factor Receptor Type 2 Messenger Ribonucleic Acid in the Rat Cardiovascular System by Urocortin, Glucocorticoids, and Cytokines
2000 · Kazunori Kageyama, Georges E. Gaudriault, et al. · Endocrinology · 70
Association between serum prolactin levels and insulin resistance in non-diabetic men
2017 · Makoto Daimon, Aya Kamba, et al. · PLoS ONE · 64
PDF
Corticotropin-Releasing Factor Receptor Type 2 Messenger Ribonucleic Acid in Rat Pituitary: Localization and Regulation by Immune Challenge, Restraint Stress, and Glucocorticoids
2003 · Kazunori Kageyama, Chien Li, et al. · Endocrinology · 64
Vasodilative Effects of Urocortin II via Protein Kinase A and a Mitogen-activated Protein Kinase in Rat Thoracic Aorta
2003 · Kazunori Kageyama, Ken-Ichi Furukawa, et al. · Journal of Cardiovascular Pharmacology · 59
Association Between Pituitary-Adrenal Axis Dominance Over the Renin-Angiotensin-Aldosterone System and Hypertension
2016 · Makoto Daimon, Aya Kamba, et al. · The Journal of Clinical Endocrinology & Metabolism · 53
Evaluation of the diagnostic criteria for Cushing’s disease in Japan [Review]
2012 · Kazunori Kageyama, Yutaka Oki, et al. · Endocrine Journal · 50
PDF
Serotonin stimulates corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats
1998 · Kazunori Kageyama, Fumiko Tozawa, et al. · Neuroscience Letters · 48
Evaluation of Diagnostic Tests for ACTH-Dependent Cushing’s Syndrome
2009 · Toshihiro SUDA, Kazunori KAGEYAMA, et al. · Endocrine Journal · 47
PDF
Evaluation of Plasma, Salivary, and Urinary Cortisol Levels for Diagnosis of Cushing’s Syndrome
2010 · Satoru SAKIHARA, Kazunori KAGEYAMA, et al. · Endocrine Journal · 41
PDF
Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells
2007 · Kazunori Kageyama, Komaki Hanada, et al. · Journal of Endocrinology · 40
PDF
Regulation of gonadotropins by corticotropin-releasing factor and urocortin
2013 · Kazunori Kageyama · Frontiers in Endocrinology · 38
PDF
Defining a serum cortisol cutoff level post-CRH stimulation for diagnosing ACTH deficiency: A retrospective study validated by a nationwide registry
2026 · Tetsushi Izuchi, Shintaro Iwama, et al. · Frontiers in Endocrinology · 37
PDF
Renal Injuries in Primary Aldosteronism: Quantitative Histopathological Analysis of 19 Patients With Primary Adosteronism
2021 · Hiroko Ogata, Yuto Yamazaki, et al. · Hypertension · 36
Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation
2019 · Kazunori Kageyama, Yuko Asari, et al. · Endocrine Journal · 35
PDF
Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells
2006 · Kazunori Kageyama, Komaki Hanada, et al. · Molecular and Cellular Endocrinology · 33
Ghrelin stimulates corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells
2011 · Kazunori Kageyama, Yukiko Kumata, et al. · Stress · 32
PDF
Ampulla (Takotsubo) Cardiomyopathy Caused by Secondary Adrenal Insufficiency in ACTH Isolated Deficiency
2007 · Satoru SAKIHARA, Kazunori KAGEYAMA, et al. · Endocrine Journal · 32
PDF
Regulation of corticotropin-releasing factor receptor type 2β mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells
2003 · Kazunori Kageyama, Georges E Gaudriault, et al. · Cellular Signalling · 32
Works count: 160
Citation count: 2,830
H-index: 28
I10-index: 82
Year
Topic
Type